Skip to main content
Equibles
SABS logo

SABS · SAB Biotherapeutics, Inc. · Proposed Sales

Track SABS — free

Use SABS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SABS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.20 +0.13 (+4.07%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$285.96M
Shares
90.99M
Volume · Oct 28 235.28K Avg daily vol (3M) 528.92K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 8 filings 8 filers Visit website Investor relations